The tumor suppressor Caliban regulates DNA damage-induced apoptosis through p53-dependent and -independent activity

Oncogene

Volumn 32, Issue 33, 2013, Pages 3857-3866

  Wang, Y ^a   Wang, Z ^a,b   Joshi, B H ^c   Puri, R K ^c   Stultz, B ^c   Yuan, Q ^a   Bai, Y ^d   Zhou, P ^e   Yuan, Z ^d   Hursh, D A ^c   Bi, X ^a,b  

^a INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d INSTITUTE OF BIOPHYSICS   (China)

^e BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Apoptosis; Caliban; p53; tumor suppressor

Indexed keywords

CALIBAN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CHROMOSOME 2; CHROMOSOME 3; CONTROLLED STUDY; DNA DAMAGE; HOMOLOGOUS RECOMBINATION; IRRADIATION; KNOCKOUT GENE; LUNG NON SMALL CELL CANCER; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA DAMAGE; DROSOPHILA; DROSOPHILA PROTEINS; GENE KNOCKOUT TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; NEOPLASMS, EXPERIMENTAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

MUS MUSCULUS;

EID: 84882453512     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.395     Document Type: Article

References (46)

1. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. Crucial role of p53- dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436: 725-730.
2. Kemp CJ, Donehower LA, Bradley A, Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993; 74: 813-822.
3. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656-660.
4. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661-665.
5. Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM et al. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints. Oncogene 1998; 16: 721-736.
6. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004; 4: 793-805.
7. Bartek J, Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001; 13: 738-747.
8. Attardi LD. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models. Mutat Res 2005; 569: 145-157.
9. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA , Butel JS et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215-221.
10. Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S et al. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 2000; 101: 91-101.
11. Brodsky MH, Nordstrom W, Tsang G, Kwan E, Rubin GM, Abrams JM. Drosophila p53 binds a damage response element at the reaper locus. Cell 2000; 101: 103-113.
12. Sogame N, Kim M, Abrams JM. Drosophila p53 preserves genomic stability by regulating cell death. Proc Natl Acad Sci USA 2003; 100: 4696-4701.
13. Matsuoka S, Ballif BA, Smogorzewska A, McDonald 3rd ER , Hurov KE, Luo J et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316: 1160-1166.
14. Sabourin M, Zakian VA. ATM-like kinases and regulation of telomerase: lessons from yeast and mammals. Trends Cell Biol 2008; 18: 337-346.
15. McKinnon PJ. ATM and ataxia telangiectasia. EMBO Rep 2004; 5: 772-776.
16. Song YH, Mirey G, Betson M, Haber DA, Settleman J. The Drosophila ATM ortholog, dATM, mediates the response to ionizing radiation and to spontaneous DNA damage during development. Curr Biol 2004; 14: 1354-1359.
17. Bi X, Wei SC, Rong YS. Telomere protection without a telomerase; the role of ATM and Mre11 in Drosophila telomere maintenance. Curr Biol 2004; 14: 1348-1353.
18. Silva E, Tiong S, Pedersen M, Homola E, Royou A, Fasulo B et al. ATM is required for telomere maintenance and chromosome stability during Drosophila development. Curr Biol 2004; 14: 1341-1347.
19. Oikemus SR, McGinnis N, Queiroz-Machado J, Tukachinsky H, Takada S, Sunkel CE et al. Drosophila atm/telomere fusion is required for telomeric localization of HP1 and telomere position effect. Genes Dev 2004; 18: 1850-1861.
20. Bi X, Jones T, Abbasi F, Lee H, Stultz B, Hursh DA et al. Drosophila caliban, a nuclear export mediator, can function as a tumor suppressor in human lung cancer cells. Oncogene 2005; 24: 8229-8239.
21. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD et al. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998; 76: 652-658.
22. Carbonnelle D, Jacquot C, Lanco X, Le Dez G, Tomasoni C, Briand G et al. Upregulation of a novel mRNA (NY-CO-1) involved in the methyl 4-methoxy-3-(3- methyl-2-butenoyl) benzoate (VT1)-induced proliferation arrest of a non-small-cell lung carcinoma cell line (NSCLC-N6). Int J Cancer 2001; 92: 388-397.
23. Chalastanis A, Penard-Lacronique V, Svrcek M, Defaweux V, Antoine N, Buhard O et al. Azathioprine-induced carcinogenesis in mice according to Msh2 genotype. J Natl Cancer Inst 2010; 102: 1731-1740.
24. Akdemir F, Christich A, Sogame N, Chapo J, Abrams JM. p53 directs focused genomic responses in Drosophila. Oncogene 2007; 26: 5184-5193.
25. Gong WJ, Golic KG. Ends-out or replacement, gene targeting in Drosophila. Proc Natl Acad Sci USA 2003; 100: 2556-2561.
26. Wichmann A, Jaklevic B, Su TT. Ionizing radiation induces caspase-dependent but Chk2- and p53-independent cell death in Drosophila melanogaster. Proc Natl Acad Sci USA 2006; 103: 9952-9957.
27. Lee JH, Lee E, Park J, Kim E, Kim J, Chung J. In vivo p53 function is indispensable for DNA damage-induced apoptotic signaling in Drosophila. FEBS Lett 2003; 550: 5-10.
28. Kornbluth S, White K. Apoptosis in Drosophila: neither fish nor fowl (nor man, nor worm). J Cell Sci 2005; 118(Part 9): 1779-1787.
29. Steller H. Regulation of apoptosis in Drosophila. Cell Death Differ 2008; 15: 1132-1138.
30. McNamee LM, Brodsky MH. p53-Independent apoptosis limits DNA damageinduced aneuploidy. Genetics 2009; 182: 423-435.
31. Moon NS, Di Stefano L, Morris EJ, Patel R, White K, Dyson NJ. E2F and p53 induce apoptosis independently during Drosophila development but intersect in the context of DNA damage. PLoS Genet 2008; 4: e1000153.
32. Fan Y, Lee TV, Xu D, Chen Z, Lamblin AF, Steller H et al. Dual roles of Drosophila p53 in cell death and cell differentiation. Cell Death Differ 2010; 17: 912-921.
33. Duffy JB. GAL4 system in Drosophila: a fly geneticists Swiss army knife. Genesis 2002; 34: 1-15.
34. Baum JS, Arama E, Steller H, McCall K. The Drosophila caspases Strica and Dronc function redundantly in programmed cell death during oogenesis. Cell Death Differ 2007; 14: 1508-1517.
35. Xue D, Horvitz HR. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 1995; 377: 248-251.
36. Lannan E, Vandergaast R, Friesen PD. Baculovirus caspase inhibitors P49 and P35 block virus-induced apoptosis downstream of effector caspase DrICE activation in Drosophila melanogaster cells. J Virol 2007; 81: 9319-9330.
37. Titen SW, Golic KG. Telomere loss provokes multiple pathways to apoptosis and produces genomic instability in Drosophila melanogaster. Genetics 2008; 180: 1821-1832.
38. Sherr CJ. Principles of tumor suppression. Cell 2004; 116: 235-246.
39. Wichmann A, Uyetake L, Su TT. E2F1 and E2F2 have opposite effects on radiation-induced p53-independent apoptosis in Drosophila. Dev Biol 2010; 346: 80-89.
40. Bennett K, Callard R, Heywood W, Harper J, Jayakumar A, LC G et al. New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J Proteome Res 2010; 9: 4289-4294.
41. Long SW, Ooi JY, Yau PM, Jones PL. A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci Rep 2011; 31: 333-343.
42. Squillaro T, Alessio N, Cipollaro M, Renieri A, Giordano A, Galderisi U. Partial silencing of methyl cytosine protein binding 2 (MECP2) in mesenchymal stem cells induces senescence with an increase in damaged DNA. FASEB J 2010; 24: 1593-1603.
43. Papait R, Magrassi L, Rigamonti D, Cattaneo E. Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells. Biochem Bioph Res Co 2009; 379: 434-439.
44. Rasti M, Arabsolghar R, Khatooni Z, Mostafavi-Pour Z. p53 Binds to estrogen receptor 1 promoter in human breast cancer cells. Pathol Oncol Res 2011; 18: 169-175.
45. Deuring R, Fanti L, Armstrong JA, Sarte M, Papoulas O, Prestel M et al. The ISWI chromatin-remodeling protein is required for gene expression and the maintenance of higher order chromatin structure in vivo. Mol Cell 2000; 5: 355-365.
46. Stultz BG, Lee H, Ramon K, Hursh DA. Decapentaplegic head capsule mutations disrupt novel peripodial expression controlling the morphogenesis of the Drosophila ventral head. Dev Biol 2006; 296: 329-339.